Skip to main content

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
68,085
Value
$17.1M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ABBV by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202668,085$17.1M0.3%+1,884+2.8%AddedHolders
Q1 202666,201$14.4M0.3%−1,872−2.7%ReducedHolders
Q4 202568,073$15.6M0.3%−9,822−12.6%ReducedHolders
Q3 202577,895$18.0M0.4%−2,251−2.8%ReducedHolders
Q2 202580,146$14.9M0.4%+1,193+1.5%AddedHolders
Q1 202578,953$16.5M0.5%+10,609+15.5%AddedHolders
Q4 202468,344$12.1M0.3%−2,067−2.9%ReducedHolders
Q3 202470,411$13.9M0.4%−312−0.4%ReducedHolders
Q2 202470,723$12.1M0.4%+5,758+8.9%AddedHolders
Q1 202464,965$11.8M0.4%−8,259−11.3%ReducedHolders
Q4 202373,224$11.4M0.4%−2,749−3.6%ReducedHolders
Q3 202375,973$11.3M0.5%+313+0.4%AddedHolders
Q2 202375,660$10.2M0.4%−16,734−18.1%ReducedHolders
Q1 202392,394$14.7M0.7%−1,410−1.5%ReducedHolders
Q4 202293,804$15.2M0.7%−3,913−4.0%ReducedHolders
Q3 202297,717$13.1M0.7%−343−0.3%ReducedHolders
Q2 202298,060$15.0M0.7%−16,557−14.4%ReducedHolders
Q1 2022114,617$18.6M0.8%−5,387−4.5%ReducedHolders
Q4 2021120,004$16.2M0.7%−4,147−3.3%ReducedHolders
Q3 2021124,151$13.4M0.6%+4,218+3.5%AddedHolders
Q2 2021119,933$13.5M0.6%+189+0.2%AddedHolders
Q1 2021119,744$13.0M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.